Promoting optimal use of beta-blockers after myocardial infarction

Am J Health Syst Pharm. 1999 May 1;56(9):858-9. doi: 10.1093/ajhp/56.9.858.
No abstract available

MeSH terms

  • Accreditation
  • Adrenergic beta-Antagonists / therapeutic use*
  • Humans
  • Myocardial Infarction / drug therapy*
  • Pharmacists / standards*

Substances

  • Adrenergic beta-Antagonists